Linagliptin – a kidney-friendly tablet for type 2 diabetes

Linagliptin – a kidney-friendly tablet for type 2 diabetes

Generic name: linagliptin [ LIN-a-GLIP-tin ]
Brand name: Tradjenta
Use: Type 2 diabetes
Tablet form: 5 mg
Drug class: Dipeptidyl peptidase 4 (DPP-4) inhibitors (‘gliptins’)

What is Linagliptin?

• A Smart Stimulant: It only prompts the pancreas to release insulin when blood sugar levels are high, reducing the risk of “hypos.” It works by increasing the levels of natural substances called incretins, which help the body control blood sugar by increasing insulin release, especially after a meal.

• “Kidney-Safe” Gliptin: Unlike many other diabetes medications, linagliptin is unique because it is not primarily cleared by the kidneys, making it a go-to option for patients with reduced kidney function. Hence, it is the only medication in its class that does not require dose adjustments, even if your kidney function declines significantly.

• Combination Therapy: It is often added to metformin or used as an alternative for patients who cannot tolerate other diabetes drugs.

Uses

• Type 2 Diabetes: It is used in adults to improve blood sugar control when diet and exercise alone are not enough.

• Patients with CKD: Because it is mainly excreted through the liver/bile rather than the kidneys, it is a preferred choice for patients with Chronic Kidney Disease (CKD).

Note: It is not used for Type 1 diabetes or for treating diabetic ketoacidosis.

Dosage

• Dose: The standard dose is 5mg once daily.

• Form: It is available as a small, film-coated tablet.

• Schedule: It can be taken at any time of the day, but it is best to take it at the same time each day to help you remember.

Note 1. Meals: Linagliptin can be taken with or without food, as its absorption is not affected by meals.

Note 2. Kidney Function: Unlike metformin or other gliptins, the dose of linagliptin remains 5mg even if your kidney function (eGFR) falls below 30 mL/min.

Side-effects

Common side-effects

• Naso-pharyngitis: Symptoms similar to a common cold (sore throat, runny nose).

• Cough: A mild, persistent cough in some patients.

• Skin Rash: Mild itching or redness.

Less common (but more serious) side-effects

• Pancreatitis: Severe, persistent abdominal pain (which may radiate to the back). If this occurs, stop the medication and see a doctor immediately.

• Joint Pain: Some patients experience severe or disabling joint pain.

• Bullous Pemphigoid: A rare skin condition causing large, fluid-filled blisters.

How It Works

• Enzyme Inhibition: It blocks an enzyme called DPP-4. This enzyme normally breaks down ‘incretin’ hormones (GLP-1 and GIP) in your gut.

• Incretin Boost: By blocking the enzyme, linagliptin keeps incretin levels higher for longer. This tells the pancreas to produce more insulin and the liver to produce less sugar.

• Meal-Time Response: It is particularly effective at managing blood sugar levels after eating, which is when sugar levels typically spike.

Monitoring

Your doctor will need to monitor:

• HbA1c Levels: Regular blood tests to ensure your sugar levels are reaching your target range.

• Pancreas Health: Your doctor should ask you to look out for signs of persistent stomach pain.

• Heart Health: While generally safe, your doctor will monitor for any signs of heart failure (like shortness of breath or swollen ankles) if you have a history of heart issues.

Comparison Table: Metformin vs. Linagliptin

Other resources

United Kingdom (UK)

• NICE Guideline [NG28]: Type 2 diabetes in adults: management

• British National Formulary (BNF): Linagliptin

United States (US)

• ADA Standards of Care in Diabetes—2026

• AACE Clinical Practice Guideline: Management of Type 2 Diabetes